Global X Genomics & Biotechnology ETF Rating $9.65 -0.55 (-5.39%) (As of 11/15/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrends Global X Genomics & Biotechnology ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.GNOM Aggregate RatingModerate Buy2.71Holdings in GNOM have an aggregate rating of Moderate Buy based on 485 analyst ratings issued in the past year covering 40 companies (96.3% of the portfolio).GNOM Aggregate Price Target$9.65High Prediction$9.65Average Prediction$9.65Low Prediction$9.65Holdings in GNOM have an aggregate price target of $9.65 and a range of $9.65 to $9.65 covering 40 companies (96.3% of the portfolio).GNOM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Genomics & Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 40 GNOM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.37%ALNYAlnylam Pharmaceuticals$235.56-8.7%4.8186 of 5 stars2.71$294.50 25.0%24Analyst DowngradeShort Interest ↓5.74%RNAAvidity Biosciences$42.18-15.6%2.5072 of 5 stars3.00$63.22 49.9%9Analyst ForecastAnalyst RevisionNews Coverage5.21%NTRANatera$146.06-3.3%2.8559 of 5 stars3.00$137.65 -5.8%17Earnings ReportAnalyst ForecastInsider SellingAnalyst RevisionNews Coverage4.87%BNTXBioNTech$99.72-3.7%3.5042 of 5 stars2.79$137.54 37.9%14Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageHigh Trading Volume4.80%VCYTVeracyte$35.94-3.0%4.5637 of 5 stars2.78$41.00 14.1%9Analyst ForecastNews CoverageHigh Trading Volume4.53%ILMNIllumina$135.05-5.1%4.3693 of 5 stars2.67$164.00 21.4%24Analyst ForecastPositive NewsHigh Trading Volume4.51%TECHBio-Techne$67.57-6.9%4.7403 of 5 stars2.67$81.78 21.0%9Analyst UpgradeHigh Trading Volume4.41%RAREUltragenyx Pharmaceutical$44.75-6.1%4.6312 of 5 stars2.92$86.69 93.7%13Analyst Forecast3.87%SRPTSarepta Therapeutics$104.54-4.2%4.9311 of 5 stars3.00$181.33 73.5%22Analyst Upgrade3.83%QGENQiagen$41.27-1.9%4.2971 of 5 stars2.60$50.88 23.3%10Analyst Revision3.69%LEGNLegend Biotech$38.19-4.3%1.8592 of 5 stars3.00$81.46 113.3%13Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews Coverage3.64%MYGNMyriad Genetics$15.25-2.7%4.3033 of 5 stars2.42$28.36 86.0%12Analyst UpgradeNews Coverage3.60%AAgilent Technologies$127.07-2.4%4.7634 of 5 stars2.50$144.36 13.6%14Short Interest ↑Positive News3.25%CRSPCRISPR Therapeutics$47.25+0.9%1.8621 of 5 stars2.37$74.94 58.6%19Insider SellingShort Interest ↑News Coverage3.19%ARWRArrowhead Pharmaceuticals$18.57-13.3%3.714 of 5 stars2.70$45.33 144.1%10Analyst UpgradeNews CoverageHigh Trading Volume2.84%BEAMBeam Therapeutics$24.05-8.6%3.0293 of 5 stars2.75$44.91 86.7%12Short Interest ↑2.75%BMRNBioMarin Pharmaceutical$63.42-3.3%4.9877 of 5 stars2.74$94.20 48.5%23Analyst ForecastInsider SellingNews Coverage2.65%RCKTRocket Pharmaceuticals$13.98-5.7%4.1676 of 5 stars2.90$51.75 270.2%10Analyst Revision2.51%NTLAIntellia Therapeutics$13.97-7.6%4.5317 of 5 stars2.75$55.36 296.3%16Gap Up2.48%GILDGilead Sciences$88.40-4.0%4.6229 of 5 stars2.68$93.86 6.2%25Analyst UpgradeShort Interest ↑News Coverage2.26%TXG10x Genomics$13.34-5.5%4.7485 of 5 stars2.53$29.19 118.8%172.22%VRTXVertex Pharmaceuticals$465.70-3.8%3.5513 of 5 stars2.53$499.12 7.2%30Analyst UpgradeNews CoveragePositive NewsHigh Trading Volume2.10%CDNACareDx$21.17-1.8%4.0677 of 5 stars2.43$29.60 39.8%71.89%MRNAModerna$36.85-7.3%4.5664 of 5 stars2.05$90.22 144.8%21Analyst ForecastOptions VolumeGap DownHigh Trading Volume1.26%VIRVir Biotechnology$8.01-7.3%3.2556 of 5 stars2.60$36.40 354.4%5Upcoming Earnings1.03%PACBPacific Biosciences of California$1.60-14.0%2.1881 of 5 stars2.47$3.63 127.3%15Analyst UpgradeAnalyst RevisionHigh Trading Volume0.81%SANASana Biotechnology$2.42-6.6%2.5344 of 5 stars2.75$13.50 457.9%4Earnings Report0.75%FLGTFulgent Genetics$17.31-2.7%4.2029 of 5 stars2.00$28.50 64.6%20.72%RGNXREGENXBIO$9.63-13.6%4.383 of 5 stars2.92$35.64 270.1%12Analyst ForecastNews CoverageGap UpHigh Trading Volume0.58%VERVVerve Therapeutics$4.79-11.0%2.3056 of 5 stars3.00$25.75 437.6%4Analyst Revision0.51%ALLOAllogene Therapeutics$2.27-7.7%2.6654 of 5 stars2.75$9.73 328.8%12Analyst ForecastShort Interest ↓News CoverageGap Up0.50%QUREuniQure$6.21-8.0%3.4776 of 5 stars2.67$17.00 174.0%6Short Interest ↓Gap Down0.45%EDITEditas Medicine$2.66-4.0%4.6339 of 5 stars2.54$9.08 241.5%13Short Interest ↓0.40%TSVT2seventy bio$3.52-10.2%2.4942 of 5 stars2.56$9.00 155.7%9News Coverage0.32%PSTXPoseida Therapeutics$2.76-14.0%4.1826 of 5 stars3.00$15.00 443.5%2Analyst ForecastNews Coverage0.28%CRBUCaribou Biosciences$1.99-4.8%2.9898 of 5 stars3.00$11.25 465.3%3Analyst ForecastShort Interest ↓News Coverage0.19%LYELLyell Immunopharma$1.100.4859 of 5 stars1.50$1.00 -9.1%2Analyst Forecast0.17%BLUEbluebird bio$0.32-11.1%2.8835 of 5 stars2.00$3.03 843.0%11Upcoming EarningsAnalyst DowngradeNews Coverage0.07%GRALGrail$14.80-6.4%0.3681 of 5 stars2.002Analyst ForecastShort Interest ↑News Coverage0.01%SCLXScilex$0.61-10.3%3.6074 of 5 stars3.00$11.33 1,758.2%3Positive News This page (NASDAQ:GNOM) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
